Clinical Trial Update: Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs

View source ↗

Summary

An update on an observational study evaluating the effect and safety of selumetinib in pediatric patients with NF1-associated plexiform neurofibromas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Selumetinib (selumetinib)

Snippet

Sponsor: AstraZeneca | Conditions: Neurofibroma, Plexiform | Status: ACTIVE_NOT_RECRUITING